Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	1.5867112068551632e-05	100.81761006289308	-216.95395722754864	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Malaria	4/50	2.654180841966383e-07	1.5867112068551632e-05	116.26086956521739	-240.55570695978312	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	3.3969235756906164e-05	74.03703703703704	-172.05130589538587	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Toll-like receptor signaling pathway	4/104	5.130876847568527e-06	7.183227586595937e-05	53.12	-132.3420645012429	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	7.183227586595937e-05	54.21768707482993	-134.5540755438832	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	0.00017924361403462858	39.774436090225564	-104.03256013781805	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	0.0002979383554686203	33.37552742616034	-89.36652156273904	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.00033000528592713166	31.349206349206348	-84.54495262531024	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	4.608088790455273e-05	0.00035840690592429903	29.721280602636536	-80.60331713278154	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.00044953237541491323	27.202072538860104	-74.37625984844887	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.0005749824463795097	24.824644549763033	-68.34725873383007	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Coronavirus disease	4/232	0.00012150057084905025	0.0007087533299527932	22.923976608187136	-63.412309433922275	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.0008055068652753352	37.56828885400314	-73.71479219141467	CXCL8;IL6;LCN2
KEGG_2021_Human	Salmonella infection	4/249	0.00015985480003693624	0.0008055068652753352	21.287074829931974	-59.07439560833883	CXCL8;IL6;MYD88;TLR4
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0008055068652753352	37.99047619047619	-74.4091590745228	CXCL8;IL6;TLR4
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.0009592774952800274	33.806223479490804	-67.40758155759835	CXCL8;MYD88;TLR4
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0009592774952800274	34.497835497835496	-68.58379435140506	CXCL8;IL6;TLR4
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.0021296790998264546	24.99579831932773	-51.672386684351224	IL6;MYD88;TLR4
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.003307227424673504	57.378571428571426	-64.24352876962546	IL6;MYD88
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.004071999883446862	19.106537530266344	-40.222430877266724	IL6;MYD88;TLR4
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.009088758172598839	13.800705467372135	-29.076248648200146	CXCL8;MYD88;TLR4
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.009088758172598839	31.765873015873016	-40.07734547796954	IL6;TLR4
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.011689825745570922	26.643333333333334	-34.49723066158141	MYD88;TLR4
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.014874681812167263	22.933908045977013	-30.23706529396038	MYD88;TLR4
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	2/100	0.006399778215208473	0.017230172117868963	20.331632653061224	-27.120602948412195	CXCL8;IL6
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.017230172117868963	20.331632653061224	-27.120602948412195	CXCL8;IL6
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.019612360127959857	18.600467289719628	-24.98176436194636	IL6;TLR4
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.019932640639279034	18.086363636363636	-24.33571316400054	MYD88;TLR4
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.03514629850161447	12.933006535947712	-17.54750234216727	CXCL8;IL6
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.03514629850161447	12.847402597402597	-17.429441058365175	CXCL8;IL6
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.049274684276008666	10.365789473684211	-13.920708621090329	CXCL8;IL6
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.049274684276008666	10.31020942408377	-13.840129933766221	CXCL8;IL6
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.05204308151740841	9.835	-13.147442958027579	IL6;MYD88
KEGG_2021_Human	Human immunodeficiency virus 1 infection	2/212	0.026851997557997137	0.05528352438411175	9.354761904761904	-12.440530405951861	MYD88;TLR4
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.059990641030377406	8.794843049327355	-11.607417281005194	CXCL8;IL6
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.0936175639398234	22.3	-12.692261742471414	CXCL8
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.0936175639398234	6.6339590443686	-8.300944532041967	CXCL8;IL6
KEGG_2021_Human	Graft-versus-host disease	1/42	0.05082096328161841	0.0936175639398234	21.75338753387534	-12.4264883862275	IL6
KEGG_2021_Human	ABC transporters	1/45	0.05436047130022726	0.0975700766927156	20.262626262626263	-11.690056551619103	DEFB1
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.10130416778683458	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Endocrine and other factor-regulated calcium reabsorption	1/53	0.06374115884515756	0.1088263687600251	17.128205128205128	-10.081098986019231	AP2B1
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.11380949514116	5.480113636363637	-6.479364551821025	IL6;TLR4
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.0753492056247738	0.12266149752870154	14.347670250896057	-8.574814690072902	IL6
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.1297295941959901	12.880837359098228	-7.74542097629872	CXCL8
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.1297295941959901	12.880837359098228	-7.74542097629872	CXCL8
KEGG_2021_Human	Synaptic vesicle cycle	1/78	0.09251851170984433	0.14078903955845876	11.531024531024531	-6.958150954500108	AP2B1
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.15794201006121963	9.961298377028713	-6.010407578745034	IL6
KEGG_2021_Human	Staphylococcus aureus infection	1/95	0.11162978125448282	0.16279343099612079	9.425531914893616	-5.678293992521663	DEFB1
KEGG_2021_Human	Hematopoietic cell lineage	1/99	0.11607356788707196	0.16581938269581709	9.036281179138323	-5.434068642481248	IL6
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.16641380960270125	8.345911949685535	-4.994589105830365	IL6
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.16641380960270125	3.816532258064516	-3.814605004177811	IL6;MYD88
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.16641380960270125	8.592233009708737	-5.152341092635986	IL6
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.16641380960270125	8.2668743509865	-4.943743954376122	IL6
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.16900859029918677	7.964964964964965	-4.748494648054986	IL6
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.17410247471391	3.5628544423440456	-3.410136075895621	CXCL8;IL6
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.18863749109098887	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Phospholipase D signaling pathway	1/148	0.16890973234869874	0.20743300463875283	5.987150415721844	-3.427000500776257	CXCL8
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.208907435265736	5.82560706401766	-3.3156870475343334	TLR4
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.21400170626948575	5.562587904360056	-3.1333425612983894	TLR4
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.21405344197790915	5.456866804692892	-3.0596637281364782	IL6
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.24151534137496347	4.5823152995927865	-2.441961042053517	CXCL8
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.24151534137496347	4.657210401891253	-2.4954112144854435	TLR4
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.25198192803375885	4.283224400871459	-2.2275706216550177	TLR4
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.26297198594152477	4.001019367991845	-2.0240281738454993	IL6
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2926511572761	3.4603806994245243	-1.6315316807371463	AP2B1
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.3087062063200445	3.184640522875817	-1.4307154955453085	IL6
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.3237988522089652	2.9484262419416005	-1.2588658824557653	MYD88
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.3299189972460628	2.8280510018214935	-1.1715156192121785	AP2B1
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.37905206350921383	2.32487922705314	-0.8103995559567543	IL6
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	IL6
